Discontinuation report KEYTRUDA

Last updated on 2019-06-28 History
Report ID 72658
Drug Identification Number 02441152
Brand name KEYTRUDA
Common or Proper name pembrolizumab for injection
Company Name MERCK CANADA INC
Active Ingredient(s) Pembrolizumab
Strength(s) 50MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 50 mg
ATC code L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-11-29
Actual discontinuation date
Remaining supply date 2019-08-23
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-06-28 French Compare
v5 2019-06-28 English Compare
v4 2019-02-27 French Compare
v3 2019-02-27 English Compare
v2 2019-01-16 French Compare
v1 2019-01-16 English Compare